BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.

J Med Chem · 2022 · PMC9791655 · PMID 36475653

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

For BAY-7081 ( 30 ), a nonsignificant trend toward higher cGMP levels was observed at 40 mg/kg.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.